Cutting-edge medical cannabis rapid test reagents - Taiwan Registration 751dcf6d172a12f4aed656810e9e70c7
Access comprehensive regulatory information for Cutting-edge medical cannabis rapid test reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 751dcf6d172a12f4aed656810e9e70c7 and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product uses competitive immunochromatography to qualitatively detect cannabis in human urine, and the test results can be used for preliminary screening. The cannabis threshold standard is set to 50ng/ml. This product can be used by both individuals and professionals.
A Clinical chemistry and clinical toxicology
A.3870 Cannabis Trial System
Contract manufacturing;; Domestic
Dates and Status
Oct 03, 2018
Nov 04, 2028